Wendy Diller

Senior Writer/Market Analyst

20 Years of Experience

About

Wendy writes on the medical devices and clinical diagnostics sectors, where she focuses on orthopedics/spine, molecular diagnostics and personalized medicine, clinical genomics, womens’ health/ femtech, and reimbursement/commercial strategy and innovation related to these specialties. She welcomes and encourages ideas and input from members of the MedTech Strategist Community.

Her career spans more than 20+ years as a top writer and manager focused on qualitative analysis of the global life sciences industry. She is Chair of Young Women in Bio Metro NY, an organization devoted to encouraging secondary students in the NY area to pursuit STEM careers and on the board of the Columbia Business School of Alumni Club NY

Specialties
Publications
Articles from Wendy Diller:
Read all from this author
Executive Interviews

In an AAOS Preview, BTIG’s Ryan Zimmerman Weighs on the 2025 Outlook for Medtech, Given Trump, Tariffs, & FDA

  • 2025-03-06 00:00:00.0
  • Wendy Diller
  • MedTech Strategist

The orthopedics and spine markets—and medtech in general—are thriving, But many procedures are elective and subject to vagaries of politics, the economy and consumer sentiment. In this video interview MedTech Strategist speaks with Ryan Zimmerman, senior equity analyst at BTIG, on the outlook for ortho/spine, 2025 prospects for the industry’s largest players, and what Zimmerman is hoping to learn at the AAOS 2025, which takes place March 10-14 in San Diego.

Read Article